Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

New Use for Duloxetine

Aschenbrenner, Diane S., MS, RN

AJN The American Journal of Nursing: March 2011 - Volume 111 - Issue 3 - p 23
doi: 10.1097/10.1097/01.NAJ.0000395235.38110.e8
Drug Watch
  • Duloxetine (Cymbalta), an antidepressant, is now approved for the treatment of chronic musculoskeletal pain.
  • The drug can have serious adverse effects, including liver damage, allergic reactions, pneumonia, and suicidal thoughts and behavior, but these are rare.
  • Adverse effects more often seen are nausea, dry mouth, insomnia, drowsiness, constipation, fatigue, and dizziness.

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch:

© 2011 Lippincott Williams & Wilkins, Inc.